This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
The Cellular Biology of Atherosclerosis
Organizer(s): Ira Tabas and Elizabeth Nabel
Date: January 22 - 27, 2005
Location: Keystone Resort, Keystone, CO, USA
Part of the Translational Medicine Series, Supported by Pfizer Global Research and Development
Summary of Meeting:
Atherosclerotic vascular disease, the leading cause of death in the industrialized world, begins when lipoproteins retained in the arterial wall provoke a series of cellular reactions involving macrophages, endothelial cells, smooth muscle cells, and immune cells. The lesion is propagated through a series of complex cell-cell and cell-lipid interactions, leading to inflammation, extracellular matrix alterations, and necrosis. These events, in turn, promote plaque disruption, acute thrombosis, and sudden vascular occlusion. The cellular processes of atherogenesis represent key therapeutic targets, but successful strategies will require a thorough understanding of the cellular and molecular mechanisms involved. In this meeting, leading cellular and molecular biologists will discuss the latest advances in these areas of research. A major goal is to spawn new interactions between researchers focused on atherogenesis per se and those with expert knowledge in cell biological areas that warrant greater representation in atherosclerosis research.
Discounted Abstract Deadline: September 22 2004
Discounted Registration Deadline: November 22 2004
We gratefully acknowledge additional support for this conference from:
American Heart AssociationNovartis Institutes for BioMedical ResearchPfizer Global Research & Development
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Exelixis, Inc.

Pfizer Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13-HL079776-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found